SVFC News IntelliCell BioSciences Files Patent App
Post# of 145246
SVFC News IntelliCell BioSciences Files Patent Application for a New Research Technique
2012-07-23 09:24 ET - News Release
NEW YORK, July 23, 2012 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("Company") (OTCQB: SVFC) announced today that it has filed a patent application for a new research technique the Company has developed for regenerative medicine.
The provisional patent, titled "ISOLATION OF STROMAL VASCULAR FRACTION FROM NON-LIVING ADIPOSE TISSUE USING ULTRASONIC CAVITATION" expands the field of cellular therapy, and specifically, research in adipose stromal vascular fraction (SVF).
For the first time SVF will be harvested from non-living adipose tissue for research and clinical purposes. Previously, only surgeons performing liposuction could supply samples of lipoaspirate cells that are then processed to yield SVF (or adipose stem cells or adipose derived regenerative cells (ADRCs).
According to IntelliCell's Chairman/CEO Steven Victor MD, "This will be transformational in the field of adipose stromal vascular fraction. SVF cells from adipose tissue will soon be readily available for researchers and institutions around the world to study and advance the field of cellular therapy with SVFs. This is an exciting discovery, yet there is significant work yet to be done before commercialization."
Robert Sexauer, EVP of Clinical Development, stated, "Much as organ donation has saved many, many lives, this process can lead to the development of new lifesaving treatments."
(0)
(0)